AMN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AMN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the three months ended in Dec. 2023, AMN Healthcare Services paid $0 Mil more to buy back shares than it received from issuing new shares. It received $365 Mil from issuing more debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0 Mil from paying cash dividends to shareholders. It spent $1 Mil on other financial activities. In all, AMN Healthcare Services earned $363 Mil on financial activities for the three months ended in Dec. 2023.
The historical data trend for AMN Healthcare Services's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AMN Healthcare Services Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Cash Flow from Financing | Get a 7-Day Free Trial | 136.60 | 211.49 | -34.90 | -591.87 | 10.73 |
AMN Healthcare Services Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Cash Flow from Financing | Get a 7-Day Free Trial | -176.34 | -44.46 | -203.29 | -105.02 | 363.50 |
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
AMN Healthcare Services's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:
Cash Flow from Financing | (A: Dec. 2023 ) | ||||||||||
= | Issuance of Stock | + | Repurchase of Stock | + | Net Issuance of Debt | + | Net Issuance of Preferred Stock | + | Cash Flow for Dividends | + | Other Financing |
= | 0 | + | -424.744 | + | 459.7 | + | 0 | + | 0 | + | -24.227 |
= | 11 |
AMN Healthcare Services's Cash from Financing for the quarter that ended in Dec. 2023 is:
Cash Flow from Financing | (Q: Dec. 2023 ) | ||||||||||
= | Issuance of Stock | + | Repurchase of Stock | + | Net Issuance of Debt | + | Net Issuance of Preferred Stock | + | Cash Flow for Dividends | + | Other Financing |
= | 0 | + | 0 | + | 364.7 | + | 0 | + | 0 | + | -1.205 |
= | 363 |
Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $11 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AMN Healthcare Services (NYSE:AMN) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
AMN Healthcare Services's issuance of stock for the three months ended in Dec. 2023 was $0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
AMN Healthcare Services's repurchase of stock for the three months ended in Dec. 2023 was $0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
AMN Healthcare Services's net issuance of debt for the three months ended in Dec. 2023 was $365 Mil. AMN Healthcare Services received $365 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
AMN Healthcare Services's net issuance of preferred for the three months ended in Dec. 2023 was $0 Mil. AMN Healthcare Services paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
AMN Healthcare Services's cash flow for dividends for the three months ended in Dec. 2023 was $0 Mil. AMN Healthcare Services received $0 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
AMN Healthcare Services's other financing for the three months ended in Dec. 2023 was $-1 Mil. AMN Healthcare Services spent $1 Mil on other financial activities.
Thank you for viewing the detailed overview of AMN Healthcare Services's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
Mark Christopher Hagan | officer: Chief Information and Digital | C/O AMN HEALTHCARE SERVICES, INC., 12400 HIGH BLUFF DRIVE, SUITE 100, SAN DIEGO CA 92130 |
Jeffrey R Knudson | officer: CFO | C/O AMN HEALTHCARE SERVICES INC., 8840 CYPRESS WATERS BOULEVARD, SUITE 300, DALLAS TX 75019 |
Whitney M Laughlin | officer: Chief Legal Officer | C/O AMN HEALTHCARE SERVICES, INC., 2999 OLYMPUS BLVD., STE 500, DALLAS TX 75019 |
Daphne E Jones | director | 275 NORTH FIELD DRIVE, LAKE FOREST IL 60045 |
Mark G Foletta | director | AMYLIN PHARMACEUTICALS INC, 9360 TOWNE CENTRE DR, SAN DIEGO CA 92121 |
Denise L Jackson | officer: General Counsel/Sr. VP | 12400 HIGH BLUFF DRIVE, SUITE 100, SAN DIEGO CA 92130 |
Caroline Grace | director, officer: Chief Executive Officer | 200 E. RANDOLPH ST., CHICAGO IL 60601 |
Douglas D Wheat | director | C/O HAAS WHEAT & PARTNERS LP, 300 CRESCENT COURT, SUITE 1700, DALLAS TX 75201 |
Susan Nowakowski | director, officer: President and COO | 14778 EL RODEO CT., RANCHO SANTA FE CA 92067 |
Jorge A. Caballero | director | C/O AMN HEALTHCARE SERVICES INC., 8840 CYPRESS WATERS BOULEVARD, SUITE 300, DALLAS TX 75019 |
Christopher S Schwartz | officer: Interim Principal Financial | C/O AMN HEALTHCARE SERVICES INC., 8840 CYPRESS WATERS BOULEVARD, SUITE 300, DALLAS TX 75019 |
R Jeffrey Harris | director | 20735 BARTLETT DRIVE, BROOKFIELD WI 53045 |
Brian M. Scott | officer: CFO/CAO | 12400 HIGH BLUFF DRIVE, SUITE 100, SAN DIEGO CA 92130 |
Martha H. Marsh | director | 9769 WEXFORD CIRCLE, GRANITE BAY CA 95746 |
Sylvia Trent-adams | director | C/O AMN HEALTHCARE SERVICES, INC., 8840 CYPRESS WATERS BLVD, SUITE 300, DALLAS TX 75019 |
From GuruFocus
By Stock market mentor Stock market mentor • 01-17-2023
By Marketwired • 08-22-2023
By sperokesalga sperokesalga • 03-28-2023
By GuruFocus Research • 11-02-2023
By Stock market mentor Stock market mentor • 01-05-2023
By James Li • 04-21-2023
By Value_Insider Value_Insider • 10-20-2022
By sperokesalga sperokesalga • 05-23-2023
By GuruFocus Research • 11-03-2023
By Marketwired • 10-23-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.